Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control and eventually paralysis.
Cell Therapy for Amyotrophic Lateral Sclerosis
We are investigating whether a new cell therapy can help patients with ALS. This study aims to explore its effects on disease progression and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital General Universitario Dr. Balmis
Neurology
Alicante, Spain
University Clinical Hospital Virgen De La Arrixaca
Hematology
Fuente-Álamo de Murcia, Spain
Sponsor: Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.